Oracle stock ticks up as Goldman turns bullish; new retail AI supply-chain tool adds focus

Oracle stock ticks up as Goldman turns bullish; new retail AI supply-chain tool adds focus

New York, Jan 12, 2026, 10:16 a.m. EST — Regular session Oracle shares nudged 0.2% higher to $198.96 in early trading Monday following Goldman Sachs’ initiation of coverage with a Buy rating and a $240 price target. So far, the stock has swung between $194.91 and $199.83 during the session. (TipRanks) The call hits a stock still battling to recover from a steep selloff, driven by concerns over debt and financing linked to Oracle’s AI data-center expansion. Since September 2025, Oracle has dropped over 40%, according to MarketWatch, which cited Deutsche Bank. (MarketWatch) Goldman analyst Gabriela Borges highlighted Oracle’s tech
SNCY stock jumps on Allegiant’s $1.5 billion bid — deal spread, regulators in focus

SNCY stock jumps on Allegiant’s $1.5 billion bid — deal spread, regulators in focus

New York, Jan 12, 2026, 09:49 AM ET — Regular session Shares of Sun Country Airlines Holdings (SNCY) jumped in early U.S. trading Monday after Allegiant Travel (ALGT) announced plans to acquire the airline in a roughly $1.5 billion deal, debt included. Sun Country’s stock rose 12.8% to $17.79, while Allegiant’s dipped 3.9% to $91.24. (Reuters) Sun Country investors aren’t just betting on an airline anymore. The stock’s price now hinges on whether the deal goes through—and how Allegiant’s shares move in the meantime. This move drags a smaller carrier into the consolidation race amid persistent cost pressures and fierce
GOOG stock slips as Google’s Gemini adds “buy” checkout with Walmart — what to watch next

GOOG stock slips as Google’s Gemini adds “buy” checkout with Walmart — what to watch next

New York, Jan 12, 2026, 10:14 EST — Regular session Alphabet’s Class C shares (GOOG), which don’t have voting rights, dropped 0.5% to $327.60 in Monday’s morning session. This came after Google introduced new shopping and checkout features for its Gemini app in partnership with Walmart and other retailers. Alphabet faces a clear challenge: as shoppers turn to chatbots for purchase advice, Google wants to keep those queries—and the resulting sales—within its ecosystem. Investors are closely monitoring if generative AI can both safeguard Google’s core search business and unlock fresh revenue streams in commerce. Walmart and Google announced that users
Synchrony Financial stock slides on Trump’s 10% credit-card rate cap push — what to know now

Synchrony Financial stock slides on Trump’s 10% credit-card rate cap push — what to know now

NEW YORK, Jan 12, 2026, 09:51 EST — Regular session Synchrony Financial shares were down about 7% at $80.80 on Monday morning, as investors sold credit-card lenders after President Donald Trump called for a one-year cap on credit-card interest rates. The proposal matters for Synchrony because it leans heavily on interest income from store and co-branded cards. A hard cap would compress what lenders earn on revolving balances, just as the sector heads into a fresh earnings cycle. Trump said on Friday he was calling for a 10% cap starting Jan. 20, but offered no details on how the plan
Meta stock dips as Zuckerberg taps Dina Powell McCormick as president — what investors watch next

Meta stock dips as Zuckerberg taps Dina Powell McCormick as president — what investors watch next

New York, January 12, 2026, 09:50 EST — Regular session. Meta Platforms, Inc. shares edged lower on Monday after the company named former Goldman Sachs executive Dina Powell McCormick as president and vice chairman, a high-profile hire as the social media group pours money into artificial intelligence infrastructure. The stock was down 0.1% at $652.24, after trading between $645.26 and $656.31. The appointment matters because Meta is trying to line up capital, power and political support for what it calls multi-billion-dollar investments in compute and data centers. Mark Zuckerberg said Powell McCormick’s global relationships make her “uniquely suited” for Meta’s
Sandisk (SNDK) stock rebounds after early dip as AI memory shortage talk keeps traders buying

Sandisk (SNDK) stock rebounds after early dip as AI memory shortage talk keeps traders buying

New York, January 12, 2026, 09:50 EST — Regular session Shares of Sandisk Corp (SNDK.O) rose 2.9% to $388.33 in early trading on Monday after slipping as much as 5.1% earlier in the session, a reminder of how jumpy this tape has become. The stock traded between $358 and $389.35. The latest move matters because Sandisk has become a high-beta read on one trade: data storage for artificial intelligence servers. The company sells products built on NAND flash — a type of memory chip used to store data in solid-state drives, or SSDs, which keep data without spinning disks. The
Affirm stock gives up premarket pop after Trump backs 10% credit-card rate cap

Affirm stock gives up premarket pop after Trump backs 10% credit-card rate cap

New York, Jan 12, 2026, 09:48 EST — Regular session Affirm Holdings’ shares slipped roughly 0.4% to $81.45 on Monday, after fluctuating between $80.90 and $84.65 in initial trades. The stock closed at $81.80 on Friday. (Investing.com) Shares dropped after President Donald Trump proposed a one-year cap on credit-card APRs at 10%. The idea hit bank and card-lender stocks but briefly boosted some alternative finance firms. Affirm climbed as much as 5% in premarket, though investors doubted the plan’s chances. Jefferies analysts called it “dead on arrival,” saying no executive power can enforce it alone. JPMorgan’s Vivek Juneja warned it
Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

Abercrombie & Fitch stock dives after holiday update trims sales outlook — what investors watch next

NEW YORK, Jan 12, 2026, 09:49 EST — Regular session Abercrombie & Fitch Co shares plunged Monday after the apparel retailer trimmed its Q4 outlook and cut the upper range of its full-year sales growth forecast post-holiday season. Early trading saw the stock drop roughly 20% to $99.62. This shift is critical since the holiday quarter is prime time for many mall-based brands, and guidance changes tend to ripple quickly through the sector. Abercrombie has maintained solid margins, so expectations were already set high. Tariffs are back on the radar as shoppers stay price-conscious. Investors aren’t just focused on holiday
Microsoft stock today: Goldman’s $655 target lands as MSFT edges higher in choppy trade

Microsoft stock today: Goldman’s $655 target lands as MSFT edges higher in choppy trade

New York, Jan 12, 2026, 09:51 EST — Regular session underway. Microsoft Corp. shares ticked up about 0.2% to $480.15 in early trading Monday in New York, bucking the trend as broader U.S. stocks slipped. Goldman Sachs kicked off coverage on the software titan with a Buy rating and set a $655 price target, signaling nearly 37% potential upside from here. (TipRanks) The timing couldn’t be more awkward. Markets jittered after Federal Reserve Chair Jerome Powell revealed the Justice Department had issued subpoenas and warned of a possible criminal indictment—sparking fresh concerns about central bank independence and driving investors into
Tesla stock pops at the open as robotaxi “prove-it year” talk meets earnings countdown

Tesla stock pops at the open as robotaxi “prove-it year” talk meets earnings countdown

New York, Jan 12, 2026, 09:34 EST — Regular session Tesla (TSLA.O) shares rose 2.1% to $445.01 in early New York trading on Monday. The early move keeps the spotlight on a stock that trades as much on expectations for new businesses as on car sales. Investors are trying to map Tesla’s next catalysts onto a market that is quick to punish misses. That backdrop is noisy this week. Traders are looking to U.S. inflation data due Tuesday and the start of quarterly earnings season for big banks, both of which can jolt rate-sensitive growth names. (Investors.com) Chief Executive Elon
Atara Biotherapeutics stock dives on FDA EBVALLO rejection — what ATRA investors watch next

Atara Biotherapeutics stock dives on FDA EBVALLO rejection — what ATRA investors watch next

New York, Jan 12, 2026, 09:54 EST — Regular session Atara Biotherapeutics shares plunged about 56% to $6.03 in early trading after the U.S. Food and Drug Administration rejected its cell therapy tabelecleucel, marketed as EBVALLO in Europe, for a rare post-transplant cancer. The stock was volatile, swinging between $4.77 and $15.40 as investors reacted to the news, with volume exceeding 1.4 million shares. (Reuters) The company said the FDA’s complete response letter — the agency’s formal notice that an application cannot be approved as submitted — came after the Jan. 9 market close. It confirmed previous Good Manufacturing Practice
Micron stock jumps as Taiwan report flags 30% rise in memory testing, packaging prices

Micron stock jumps as Taiwan report flags 30% rise in memory testing, packaging prices

New York, Jan 12, 2026, 09:35 EST — Regular session Micron Technology (MU) shares rose 5.5% to $345.09 in early New York trading on Monday after a Taiwanese media report said memory-chip testing and packaging firms have started lifting prices by up to 30%. (UDN) The timing matters. Packaging and testing sit at the back end of the supply chain, and tight capacity there can slow shipments even if chipmakers push wafer output higher. For Micron, any sign of a bottleneck tends to pull attention back to pricing power. The work is known as OSAT — outsourced semiconductor assembly and

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
Go toTop